JNA
MCID: JVN033
MIFTS: 44

Juvenile Nasopharyngeal Angiofibroma (JNA)

Categories: Rare diseases

Aliases & Classifications for Juvenile Nasopharyngeal Angiofibroma

MalaCards integrated aliases for Juvenile Nasopharyngeal Angiofibroma:

Name: Juvenile Nasopharyngeal Angiofibroma 58
Nasopharyngeal Angiofibroma 71
Jna 58

Characteristics:

Orphanet epidemiological data:

58
juvenile nasopharyngeal angiofibroma
Inheritance: Not applicable; Age of onset: Adolescent,Childhood;

Classifications:



External Ids:

ICD10 via Orphanet 33 D10.6
Orphanet 58 ORPHA289596
UMLS 71 C1367536

Summaries for Juvenile Nasopharyngeal Angiofibroma

MalaCards based summary : Juvenile Nasopharyngeal Angiofibroma, also known as nasopharyngeal angiofibroma, is related to rare tumor and oropharynx cancer, and has symptoms including dyspnea, headache and tinnitus. An important gene associated with Juvenile Nasopharyngeal Angiofibroma is ESR1 (Estrogen Receptor 1), and among its related pathways/superpathways are Akt Signaling and Toll-like Receptor Signaling Pathway. Affiliated tissues include breast, brain and bone, and related phenotypes are juvenile nasopharyngeal angiofibroma and diplopia

Wikipedia : 74 Nasopharyngeal angiofibroma is a histologically benign but locally aggressive vascular tumor of the... more...

Related Diseases for Juvenile Nasopharyngeal Angiofibroma

Diseases related to Juvenile Nasopharyngeal Angiofibroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 296)
# Related Disease Score Top Affiliating Genes
1 rare tumor 31.2 KIT ACTC1
2 oropharynx cancer 30.5 VEGFA PGR KIT
3 telangiectasis 30.5 VEGFA ENG BMP6
4 papilloma 30.4 VEGFA PCNA ESR1 ACTC1
5 angiomyolipoma 30.3 PGR KIT ESR1 ACTC1
6 histiocytoma 30.2 PECAM1 KIT ACTC1
7 fibrosarcoma 30.0 MYC KIT FGF2 ACTC1
8 vascular cancer 29.7 VEGFA PECAM1 KIT FGF2 ENG
9 leiomyosarcoma 29.5 VEGFA PGR PECAM1 KIT ESR1 ACTC1
10 sarcoma 29.1 VEGFA TLR3 MYC KIT FGF2 ACTC1
11 hemangioma 29.1 VEGFA PGR PECAM1 MYC KIT FGF2
12 glassy cell carcinoma of the cervix 10.6 PGR ESR1
13 bartholin's gland adenoid cystic carcinoma 10.6 PGR ESR1
14 chronic tympanitis 10.6 PGR ESR1
15 bartholin's gland adenoma 10.6 PGR ESR1
16 granulomatous endometritis 10.6 PGR ESR1
17 bartholin's gland benign neoplasm 10.6 PGR ESR1
18 vestibular gland benign neoplasm 10.6 PGR ESR1
19 scleromyxedema 10.5 FGF2 ACTC1
20 lymphangiomatosis 10.5 PGR PCNA
21 breast juvenile papillomatosis 10.5 PGR ESR1
22 lung leiomyoma 10.5 PGR ESR1
23 vulvar syringoma 10.5 PGR ESR1
24 trigonitis 10.5 PGR ESR1
25 breast scirrhous carcinoma 10.5 PGR ESR1
26 oncocytic breast carcinoma 10.5 PGR ESR1
27 calcifying aponeurotic fibroma 10.5 PGR ACTC1
28 adult type testicular granulosa cell tumor 10.5 PGR ESR1
29 ovarian seromucinous carcinoma 10.5 PGR ESR1
30 breast papillary carcinoma 10.5 PGR ESR1
31 breast leiomyoma 10.5 PGR ESR1
32 intravascular papillary endothelial hyperplasia 10.5 VEGFA ACTC1
33 intravenous leiomyomatosis 10.5 PGR ESR1
34 glycogen-rich clear cell breast carcinoma 10.5 PGR ACTC1
35 comedo carcinoma 10.5 PGR ESR1
36 breast metaplastic carcinoma 10.5 PGR ESR1
37 lipodermatosclerosis 10.4 VEGFA PCNA
38 familial adenomatous polyposis 10.4
39 branch retinal artery occlusion 10.4
40 central retinal artery occlusion 10.4
41 retinal artery occlusion 10.4
42 exophthalmos 10.4
43 lipid-rich carcinoma 10.4 PGR ESR1
44 postmenopausal atrophic vaginitis 10.4 ESR1 CYP19A1
45 vaginal endometrial stromal sarcoma 10.4 PGR ESR1
46 ovarian fibrothecoma 10.4 KIT ACTC1
47 pyometritis 10.4 PGR BMI1
48 breast myoepithelial carcinoma 10.4 PGR ACTC1
49 myxoid leiomyosarcoma 10.4 PGR ACTC1
50 facial paralysis 10.4

Graphical network of the top 20 diseases related to Juvenile Nasopharyngeal Angiofibroma:



Diseases related to Juvenile Nasopharyngeal Angiofibroma

Symptoms & Phenotypes for Juvenile Nasopharyngeal Angiofibroma

Human phenotypes related to Juvenile Nasopharyngeal Angiofibroma:

58 31 (show all 8)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 juvenile nasopharyngeal angiofibroma 58 31 obligate (100%) Obligate (100%) HP:0030429
2 diplopia 58 31 frequent (33%) Frequent (79-30%) HP:0000651
3 proptosis 58 31 frequent (33%) Frequent (79-30%) HP:0000520
4 epistaxis 58 31 frequent (33%) Frequent (79-30%) HP:0000421
5 nasal obstruction 58 31 frequent (33%) Frequent (79-30%) HP:0001742
6 facial edema 58 31 frequent (33%) Frequent (79-30%) HP:0000282
7 increased intracranial pressure 58 31 occasional (7.5%) Occasional (29-5%) HP:0002516
8 juvenile colonic polyposis 58 31 very rare (1%) Very rare (<4-1%) HP:0012198

UMLS symptoms related to Juvenile Nasopharyngeal Angiofibroma:


dyspnea, headache, tinnitus

GenomeRNAi Phenotypes related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death HMECs cells GR00103-A-0 9.17 BMI1 BMP6 ENG MYC PCNA PGR

MGI Mouse Phenotypes related to Juvenile Nasopharyngeal Angiofibroma:

45 (show all 17)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.39 CYP11A1 CYP19A1 ENG ESR1 FGF2 KIT
2 cardiovascular system MP:0005385 10.37 ACTC1 CYP11A1 CYP19A1 ENG ESR1 FGF2
3 homeostasis/metabolism MP:0005376 10.37 ACTC1 CYP11A1 CYP19A1 ENG ESR1 FGF2
4 cellular MP:0005384 10.36 ACTC1 CYP11A1 CYP19A1 ESR1 FGF2 KIT
5 behavior/neurological MP:0005386 10.31 CYP11A1 CYP19A1 ENG ESR1 FGF2 KIT
6 immune system MP:0005387 10.29 CYP11A1 CYP19A1 ESR1 KIT MYC PCNA
7 mortality/aging MP:0010768 10.28 ACTC1 CYP11A1 ENG ESR1 FGF2 KIT
8 endocrine/exocrine gland MP:0005379 10.22 CYP11A1 CYP19A1 ESR1 KIT MYC PCNA
9 digestive/alimentary MP:0005381 10.19 CYP19A1 ENG ESR1 KIT MYC PECAM1
10 muscle MP:0005369 10.18 ACTC1 CYP11A1 CYP19A1 ENG ESR1 FGF2
11 normal MP:0002873 10.02 ACTC1 CYP11A1 CYP19A1 ENG ESR1 KIT
12 liver/biliary system MP:0005370 10 CYP11A1 CYP19A1 ESR1 KIT MYC PECAM1
13 reproductive system MP:0005389 9.93 BMP6 CYP11A1 CYP19A1 ESR1 FGF2 KIT
14 neoplasm MP:0002006 9.91 ESR1 FGF2 KIT MYC PGR TLR3
15 renal/urinary system MP:0005367 9.8 CYP19A1 ESR1 KIT PECAM1 TLR7 TLR9
16 respiratory system MP:0005388 9.5 ENG ESR1 KIT PECAM1 TGFB3 TLR3
17 skeleton MP:0005390 9.32 BMP6 CYP19A1 ESR1 FGF2 KIT MYC

Drugs & Therapeutics for Juvenile Nasopharyngeal Angiofibroma

Search Clinical Trials , NIH Clinical Center for Juvenile Nasopharyngeal Angiofibroma

Genetic Tests for Juvenile Nasopharyngeal Angiofibroma

Anatomical Context for Juvenile Nasopharyngeal Angiofibroma

MalaCards organs/tissues related to Juvenile Nasopharyngeal Angiofibroma:

40
Breast, Brain, Bone, Prostate, Endothelial, Heart, Ovary

Publications for Juvenile Nasopharyngeal Angiofibroma

Articles related to Juvenile Nasopharyngeal Angiofibroma:

(show top 50) (show all 740)
# Title Authors PMID Year
1
Trimodal embolization of juvenile nasopharyngeal angiofibroma with intracranial extension. 61
31864085 2020
2
Sirolimus for the treatment of juvenile nasopharyngeal angiofibroma. 61
31925925 2020
3
Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck. 61
31950474 2020
4
Recurrence Rate after Endoscopic vs. Open Approaches for Juvenile Nasopharyngeal Angiofibroma: A Meta-analysis. 61
31750043 2019
5
Juvenile Nasopharyngeal Angiofibroma Outcomes and Cost: Analysis of the Kids' Inpatient Database. 61
31876164 2019
6
Tissue microarray analysis reveals that cofilin expression is a poor prognostic factor in juvenile nasopharyngeal angiofibroma. 61
31623023 2019
7
Is 'Group and Save' Blood Request Routinely Required for Nasopharyngeal Biopsy? 61
31763234 2019
8
The Genetic and Molecular Determinants of Juvenile Nasopharyngeal Angiofibroma: A Systematic Review. 61
31148463 2019
9
Massive Angiomatous Nasal Polyp Mimicking Nasopharyngeal Angiofibroma. 61
31763304 2019
10
Extra Nasopharyngeal Angiofibroma from Lateral Nasal Wall: A Rare Case Report. 61
31763305 2019
11
Juvenile nasopharyngeal angiofibroma with intracranial extension - diagnosis and treatment. 61
32022702 2019
12
From Juvenile Nasopharyngeal Angiofibroma to Nasopharyngeal Carcinoma; A Rare Case Report of Nasopharyngeal Mass. 61
31858008 2019
13
Nasolacrimal Duct Management During Endoscopic Sinus and Skull Base Surgery. 61
31088142 2019
14
Endoscopic Resection of Pediatric Skull Base Tumors: An Evidence-Based Review. 61
31534896 2019
15
Juvenile nasopharyngeal angiofibroma surgical treatment in paediatric patients. 61
30093086 2019
16
Juvenile nasopharyngeal angiofibroma in prepubertal males: A diagnostic dilemma. 61
30569464 2019
17
Nasopharyngeal Angiofibroma Staging with a Novel Nominal Basis: An 18-Year Study in a Tertiary Center. 61
31012381 2019
18
Case Series of Pre-Operative Endovascular Embolization of Nasopharyngeal Angiofibroma Using Polyvinyl Alcohol Foam Particle: A Single Centre Experience. 61
31666855 2019
19
Posterior Nasal Pack After Transpalatal Excision of Juvenile Nasopharyngeal Angiofibroma: Can It be Avoided? 61
31275844 2019
20
Current perspectives on the origin theory of juvenile nasopharyngeal angiofibroma. 61
31421693 2019
21
Occurrence of Hemi-Central Retinal Artery Occlusion Following Embolization in a Case of Recurrent Juvenile Nasopharyngeal Angiofibroma. 61
31233156 2019
22
Nasal Angiomyolipoma (AML) Mimicking Juvenile Nasopharyngeal Angiofibroma. 61
31223601 2019
23
Juvenile nasopharyngeal angiofibroma: A retrospective study of 27 cases in the ENT department of IPO-PORTO. 61
30739390 2019
24
The risk factors for residual juvenile nasopharyngeal angiofibroma and the usual residual sites. 61
30885446 2019
25
Transoral Finger-Retraction for Endonasal Endoscopic Resection of Masseteric and Buccal Space Lesions. 61
30614990 2019
26
Endoscopic endonasal transmaxillary ligation of a feeding artery and coblation plasma technology enables en bloc resection of advanced juvenile nasopharyngeal angiofibroma without preoperative embolization. 61
29980404 2019
27
Efficacy and safety of preoperative internal maxillary arterial embolization with gelfoam for nasopharyngeal angiofibroma. 61
30604064 2019
28
Newly detected DNA viruses in juvenile nasopharyngeal angiofibroma (JNA) and oral and oropharyngeal squamous cell carcinoma (OSCC/OPSCC). 61
30578435 2019
29
Nasal septum angiofibroma: a rare condition with an unusual onset. 61
30847296 2019
30
Nasopharyngeal Angiofibroma: A Forgotten Entity in Older Patients. 61
31040732 2019
31
Implication of embolization in residual disease in lateral extension of juvenile nasopharyngeal angiofibroma. 61
30619704 2019
32
Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review. 61
30387011 2019
33
Nasopharyngeal angiofibroma in an elderly female patient: A rare case report. 61
30546905 2018
34
Cerebrospinal Fluid Leak in Juvenile Nasopharyngeal Angiofibroma-Rare Sequelae of Flutamide-Induced Tumor Shrinkage. 61
30099189 2018
35
Morbidity and Volumetric Progression in Juvenile Nasopharyngeal Angiofibroma in a Long-Term Follow-Up. 61
30456021 2018
36
A case of nasopharyngeal angiofibroma removed using a minimally invasive endoscopic endonasal technique. 61
30524630 2018
37
Juvenile nasopharyngeal angiofibroma: a single centre's 11-year experience. 61
30345941 2018
38
A rare presentation of a paediatric sinonasal inverted papilloma. 61
30515294 2018
39
Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma. 61
30171340 2018
40
Atypical angiofibroma in a patient with compromised general health: A case report. 61
30305895 2018
41
Comparative Study between Conventional Method and Endonasal Endoscopic Resection of Juvenile Nasopharyngeal Angiofibroma. 61
30487495 2018
42
Infratemporal fossa tumors: When to suspect a malignant tumor? A retrospective cohort study of 62 cases. 61
30005880 2018
43
A Man with Juvenile Nasopharyngeal Angiofibroma, Vestibular Schwannoma, Cleft Lip and Cleft Palate, and Various Nevi: Case Report and Review. 61
30891371 2018
44
Differential Gene Expression and Pathway Analysis in Juvenile Nasopharyngeal Angiofibroma Using RNA Sequencing. 61
29634432 2018
45
Management and Outcome in Patients with Advanced Juvenile Nasopharyngeal Angiofibroma. 61
30009116 2018
46
Transnasal microscopic approach for juvenile nasopharyngeal angiofibroma. 61
30460914 2018
47
Assisted resection of lateral extension of juvenile nasopharyngeal angiofibroma using a sphenopalatine fossa dissector. 61
29909791 2018
48
Cumulative sum analysis of the learning curve for endoscopic resection of juvenile nasopharyngeal angiofibroma. 61
29368283 2018
49
Juvenile Nasopharyngeal Angiofibroma With Sphenoid Sinus Invasion and Protrusion: Treatment Approach With Le Fort I Osteotomy. 61
29481518 2018
50
Hypoxia-Inducible Factor-1α (HIF-1α) Expression on Endothelial Cells in Juvenile Nasopharyngeal Angiofibroma: A Review of 70 cases and Tissue Microarray Analysis. 61
29717655 2018

Variations for Juvenile Nasopharyngeal Angiofibroma

Expression for Juvenile Nasopharyngeal Angiofibroma

Search GEO for disease gene expression data for Juvenile Nasopharyngeal Angiofibroma.

Pathways for Juvenile Nasopharyngeal Angiofibroma

Pathways related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

(show all 30)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.32 TLR9 TLR7 TLR3 TGFB3 KIT FGF2
2
Show member pathways
13.03 TLR9 TLR7 TLR3 TGFB3 PCNA MYC
3
Show member pathways
12.79 VEGFA TGFB3 PCNA MYC KIT
4 12.68 VEGFA TGFB3 MYC KIT FGF2
5 12.66 VEGFA TGFB3 MYC KIT FGF2 ESR1
6
Show member pathways
12.51 TGFB3 PGR MYC KIT FGF2 ESR1
7 12.42 TLR9 TLR7 TLR3 PECAM1 KIT
8
Show member pathways
12.25 TLR9 TLR7 TLR3 TGFB3 FGF2 BMP6
9 12.21 VEGFA MYC FGF2 ESR1
10
Show member pathways
12.13 TGFB3 MYC KIT FGF2 BMP6
11 12.02 VEGFA MYC ESR1 CYP19A1
12 11.92 VEGFA MYC FGF2 BMI1
13
Show member pathways
11.89 TLR9 TLR7 TLR3 TGFB3
14 11.8 TGFB3 MYC BMP6
15 11.74 TLR9 TLR7 TLR3
16 11.7 VEGFA FGF2 BMI1
17 11.69 TGFB3 MYC ESR1 ENG
18 11.67 TLR9 TLR7 KIT
19 11.59 VEGFA FGF2 BMP6
20
Show member pathways
11.59 VEGFA MYC KIT ESR1
21 11.51 TGFB3 PECAM1 FGF2 ENG
22 11.49 KIT FGF2 ACTC1
23 11.46 TLR9 TGFB3 PECAM1
24 11.44 CYP19A1 CYP11A1 BMP6
25 11.42 VEGFA MYC ESR1
26 11.37 VEGFA MYC FGF2
27 11.32 VEGFA TLR9 TLR7 TLR3 TGFB3 MYC
28 11.02 VEGFA TGFB3 FGF2
29 10.94 VEGFA TGFB3 KIT FGF2
30 10.15 ESR1 CYP19A1

GO Terms for Juvenile Nasopharyngeal Angiofibroma

Cellular components related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.61 VEGFA TLR3 TGFB3 PECAM1 KIT FGF2
2 early phagosome GO:0032009 9.16 TLR9 TLR7
3 endolysosome membrane GO:0036020 8.8 TLR9 TLR7 TLR3

Biological processes related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

(show all 44)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of transcription by RNA polymerase II GO:0000122 10.13 VEGFA PCNA MYC ESR1 BMP6 BMI1
2 signal transduction GO:0007165 10.13 VEGFA TLR9 TLR7 TLR3 TGFB3 PGR
3 cytokine-mediated signaling pathway GO:0019221 9.99 VEGFA MYC KIT FGF2
4 inflammatory response GO:0006954 9.99 TLR9 TLR7 TLR3 KIT BMP6
5 positive regulation of cell proliferation GO:0008284 9.99 VEGFA TGFB3 MYC KIT FGF2 BMP6
6 negative regulation of gene expression GO:0010629 9.98 VEGFA PGR ESR1 ENG
7 angiogenesis GO:0001525 9.96 VEGFA PECAM1 FGF2 ENG
8 positive regulation of protein kinase B signaling GO:0051897 9.9 KIT FGF2 ESR1 ENG
9 wound healing GO:0042060 9.86 TGFB3 PECAM1 FGF2
10 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.86 VEGFA PECAM1 BMP6
11 positive regulation of angiogenesis GO:0045766 9.86 VEGFA TLR3 FGF2 ENG
12 BMP signaling pathway GO:0030509 9.85 TGFB3 ENG BMP6
13 positive regulation of inflammatory response GO:0050729 9.84 TLR9 TLR7 TLR3
14 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.83 VEGFA PECAM1 KIT
15 positive regulation of endothelial cell proliferation GO:0001938 9.83 VEGFA FGF2 BMP6
16 I-kappaB kinase/NF-kappaB signaling GO:0007249 9.81 TLR9 TLR7 TLR3
17 positive regulation of epithelial cell proliferation GO:0050679 9.81 VEGFA MYC BMP6
18 positive regulation of MAP kinase activity GO:0043406 9.8 VEGFA KIT FGF2
19 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.79 TLR9 TLR7 TLR3
20 positive regulation of interleukin-6 production GO:0032755 9.79 TLR9 TLR7 TLR3
21 positive regulation of fibroblast proliferation GO:0048146 9.78 MYC ESR1 BMI1
22 positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862 9.76 TGFB3 ENG BMP6
23 cellular response to mechanical stimulus GO:0071260 9.76 TLR7 TLR3 ENG BMP6
24 positive regulation of cell division GO:0051781 9.75 VEGFA TGFB3 FGF2
25 toll-like receptor signaling pathway GO:0002224 9.74 TLR9 TLR7 TLR3
26 mammary gland development GO:0030879 9.7 TGFB3 PGR CYP19A1
27 positive regulation of DNA biosynthetic process GO:2000573 9.69 MYC FGF2
28 positive regulation of interleukin-8 biosynthetic process GO:0045416 9.68 TLR9 TLR7
29 positive regulation of SMAD protein signal transduction GO:0060391 9.67 TGFB3 BMP6
30 positive regulation of vascular permeability GO:0043117 9.67 VEGFA BMP6
31 positive regulation of interleukin-8 production GO:0032757 9.67 TLR9 TLR7 TLR3
32 negative regulation of cell-cell adhesion mediated by cadherin GO:2000048 9.65 VEGFA BMP6
33 positive regulation of chemokine production GO:0032722 9.65 TLR9 TLR7 TLR3
34 positive regulation of transcription by RNA polymerase II GO:0045944 9.65 VEGFA TLR9 TLR3 TGFB3 PGR MYC
35 positive regulation of vascular smooth muscle cell differentiation GO:1905065 9.64 KIT ENG
36 paracrine signaling GO:0038001 9.62 PGR FGF2
37 positive regulation of interferon-gamma biosynthetic process GO:0045078 9.58 TLR9 TLR7 TLR3
38 positive regulation of toll-like receptor signaling pathway GO:0034123 9.55 TLR9 TLR3
39 negative regulation of adherens junction organization GO:1903392 9.54 VEGFA BMP6
40 positive regulation of phospholipase C activity GO:0010863 9.54 KIT FGF2 ESR1
41 I-kappaB phosphorylation GO:0007252 9.5 TLR9 TLR7 TLR3
42 positive regulation of interferon-beta biosynthetic process GO:0045359 9.43 TLR9 TLR7 TLR3
43 positive regulation of interferon-alpha biosynthetic process GO:0045356 9.33 TLR9 TLR7 TLR3
44 positive regulation of gene expression GO:0010628 9.23 VEGFA TLR9 TLR3 MYC KIT ENG

Molecular functions related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.7 VEGFA TLR3 TGFB3 PGR PCNA ESR1
2 cytokine activity GO:0005125 9.62 VEGFA TGFB3 FGF2 BMP6
3 siRNA binding GO:0035197 9.43 TLR9 TLR7
4 signaling pattern recognition receptor activity GO:0008329 9.4 TLR9 TLR7
5 type I transforming growth factor beta receptor binding GO:0034713 9.37 TGFB3 ENG
6 type II transforming growth factor beta receptor binding GO:0005114 9.26 TGFB3 ENG
7 transmembrane signaling receptor activity GO:0004888 9.26 TLR9 TLR7 TLR3 ENG
8 growth factor activity GO:0008083 8.92 VEGFA TGFB3 FGF2 BMP6

Sources for Juvenile Nasopharyngeal Angiofibroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....